# Venn Biosciences Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/venn-biosciences

- Industry: Healthcare Specialists
- Headquarters: San Francisco, US
- Website: www.intervenn.bio
- Total disclosed funding: $213M
- Latest round: Series C (Aug 2, 2021)
- Investors on record: 12

## About

Founded in 2017 and based in California, US, Venn Biosciences Corporation is building a liquid-biopsy solutions platform. The company was founded by CEO Aldo Carrascoso. In August 2021, Venn Biosciences raised USD 201 million in Series C funding co-led by Heritage Provider Network, Highside Capital Management, Irving Investors, and SoftBank Group.

The company utilizes a proprietary glycoproteomics biomarker interrogation platform using AI and mass spectrometry for next-gen precision medicine. Venn Biosciences is also working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression. The company is using AI-powered software for glycoprotein analysis, biomarker research, liquid-biopsy assay development, and new drug target discovery.

The company plans to use its funding from August 2021 to accelerate the development and commercialization of Dawn™, the company’s liquid biopsy assay for immune checkpoint inhibitor response prediction, and to expand the network of partners on the company’s AI-driven glycoproteomics platform.

## Funding rounds

- Series C, Aug 2, 2021, $173M — True Ventures, SoftBank Group, Amplify Partners, Heritage Provider Network, Genoa Ventures, Anzu Partners, Irving Investors, Highside Capital Management
- Series B, Jul 13, 2020, $32M — True Ventures, Amplify Partners, Xeraya Capital, Genoa Ventures, Anzu Partners
- Series A, Nov 7, 2019, $1M — True Ventures, Amplify Partners, Boost VC, Genoa Ventures, Prado SV
- Series A, Oct 3, 2018, $6.5M — True Ventures, Amplify Partners, Boost VC, Genoa Ventures, Prado SV
- Seed, Apr 1, 2017 — Boost VC, Matadero Capital

## Investors

- Boost VC (https://capitalatlas.ai/funds/boost-vc) — Seed, Series A
- Matadero Capital (https://capitalatlas.ai/funds/matadero-capital) — Seed
- True Ventures (https://capitalatlas.ai/funds/true-ventures) — Series A, Series B, Series C
- Amplify Partners (https://capitalatlas.ai/funds/amplify-partners) — Series A, Series B, Series C
- Genoa Ventures (https://capitalatlas.ai/funds/genoa-ventures) — Series A, Series B, Series C
- Prado SV (https://capitalatlas.ai/funds/prado-sv) — Series A
- Xeraya Capital (https://capitalatlas.ai/funds/xeraya-capital) — Series B
- Anzu Partners (https://capitalatlas.ai/funds/anzu-partners) — Series B, Series C
- SoftBank Group — Series C
- Heritage Provider Network — Series C
- Irving Investors (https://capitalatlas.ai/funds/irving-investors) — Series C
- Highside Capital Management — Series C